-
Gene Therapy Seen to Raise Response to Levodopa Given as IV Infusion in Trial
A substudy in a Phase 1 trial of Parkinson’s patients given levodopa once by IV (and the gene therapy VY‐AADC01), found good motor responses at low dose. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.